| scholarly article | Q13442814 |
| P50 | author | Michal Mokry | Q58540851 |
| P2093 | author name string | Paul J Coffer | |
| Menno P Creyghton | |||
| Edward E S Nieuwenhuis | |||
| Stephin J Vervoort | |||
| Berent J Prakken | |||
| Femke van Wijk | |||
| Gerdien Mijnheer | |||
| Janneke G C Peeters | |||
| Jorg van Loosdregt | |||
| Sebastiaan J Vastert | |||
| Sytze de Roock | |||
| Sander C Tan | |||
| P433 | issue | 12 | |
| P921 | main subject | disease-related genes | Q104819440 |
| P304 | page(s) | 1986-1996 | |
| P577 | publication date | 2015-09-15 | |
| P1433 | published in | Cell Reports | Q5058165 |
| P1476 | title | Inhibition of Super-Enhancer Activity in Autoinflammatory Site-Derived T Cells Reduces Disease-Associated Gene Expression | |
| P478 | volume | 12 |
| Q47313269 | Activation of Mouse Tcrb: Uncoupling RUNX1 Function from Its Cooperative Binding with ETS1. |
| Q38782827 | Autoimmune disease-associated gene expression is reduced by BET-inhibition |
| Q39027949 | Biogenesis and Transcriptional Regulation of Long Noncoding RNAs in the Human Immune System. |
| Q60054289 | Bromodomain protein inhibition: a novel therapeutic strategy in rheumatic diseases |
| Q38851252 | ChIP-seq in studying epigenetic mechanisms of disease and promoting precision medicine: progresses and future directions |
| Q33751386 | Chemical probes targeting epigenetic proteins: Applications beyond oncology |
| Q38807143 | Developmental Control of NRAMP1 (SLC11A1) Expression in Professional Phagocytes |
| Q100684173 | Dysregulated RASGRP1 expression through RUNX1 mediated transcription promotes autoimmunity |
| Q51553005 | Engineering of the epigenome: synthetic biology to define functional causality and develop innovative therapies. |
| Q90669058 | Epigenetic Mechanisms Dictating Eradication of Cancer by Natural Killer Cells |
| Q37714196 | Epigenetic intervention with a BET inhibitor ameliorates acute retinal ganglion cell death in mice |
| Q42776292 | Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants. |
| Q47131782 | FOXP1 Promotes Embryonic Neural Stem Cell Differentiation by Repressing Jagged1 Expression |
| Q91871661 | From Super-Enhancer Non-coding RNA to Immune Checkpoint: Frameworks to Functions |
| Q97886082 | Functions and Clinical Significance of Super-Enhancers in Bone-Related Diseases |
| Q33752910 | Genetic insights into juvenile idiopathic arthritis derived from deep whole genome sequencing |
| Q90482460 | Genome-Wide Maps of Transcription Regulatory Elements and Transcription Enhancers in Development and Disease |
| Q33593001 | Higher-Order Chromatin Regulation of Inflammatory Gene Expression |
| Q64121465 | Identification and characterization of the lncRNA signature associated with overall survival in patients with neuroblastoma |
| Q39171371 | Identification of potential peripheral blood diagnostic biomarkers for patients with juvenile idiopathic arthritis by bioinformatics analysis |
| Q39031414 | Immune disease-associated variants in gene enhancers point to BET epigenetic mechanisms for therapeutic intervention |
| Q92972636 | Immunomics in Pediatric Rheumatic Diseases |
| Q47907119 | Increased autophagy contributes to the inflammatory phenotype of juvenile idiopathic arthritis synovial fluid T cells. |
| Q39087159 | Lingering Questions about Enhancer RNA and Enhancer Transcription-Coupled Genomic Instability |
| Q60916259 | Pregnancy Epigenetic Signature in T Helper 17 and T Regulatory Cells in Multiple Sclerosis |
| Q47808045 | Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells |
| Q64241032 | Restoring T Cell Tolerance, Exploring the Potential of Histone Deacetylase Inhibitors for the Treatment of Juvenile Idiopathic Arthritis |
| Q40044046 | Review article: next-generation transformative advances in the pathogenesis and management of autoimmune hepatitis |
| Q39407376 | Review: Enhancers in Autoimmune Arthritis: Implications and Therapeutic Potential |
| Q38748150 | Selective targeting of epigenetic reader domains |
| Q39689800 | T-bet Activates Th1 Genes through Mediator and the Super Elongation Complex |
| Q39141456 | Targeting Cancer Cells with BET Bromodomain Inhibitors |
| Q55454424 | Targeting Super-Enhancers for Disease Treatment and Diagnosis. |
| Q61809085 | Targeting Tregs in Juvenile Idiopathic Arthritis and Juvenile Dermatomyositis-Insights From Other Diseases |
| Q64075187 | The Association Between Vitamin D and Multiple Sclerosis Risk: 1,25(OH)D Induces Super-Enhancers Bound by VDR |
| Q53115968 | Towards quantitative analysis of gene regulation by enhancers. |
| Q61445278 | Transcriptionally induced enhancers in the macrophage immune response to Mycobacterium tuberculosis infection |
| Q57177957 | Under-Evaluated or Unassessed Pathogenic Pathways in Autoimmune Hepatitis and Implications for Future Management |
Search more.